The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4303922 4100782 I 4303922-5 20031201 20040211 20040223 EXP 163-20785-04020338 CELGENE CORPORATION 69 YR M N 20040212 20031226

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4303922 1004651295 PS THALOMID 1 ORAL 200 MG, DAILY, ORAL D D 20785

Indications of drugs used

Event ID DRUG SEQ INDI PT
4303922 1004651295 DRUG USE FOR UNKNOWN INDICATION

Outcome of event

Event ID OUTC COD
4303922 DE
4303922 HO

Reactions reported

Event ID PT
4303922 AMMONIA INCREASED
4303922 COMA
4303922 ENCEPHALOPATHY
4303922 MULTIPLE MYELOMA
4303922 PNEUMONIA ASPIRATION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4303922 OTH

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4303922 1004651295 1 YR